Study In JAMA Shows Patients Treated With Abbott’s XIENCE™ V Drug Eluting Stent Experience Better Outcomes Than Market Leading Drug Eluting Sten
April 28th, 2008 by 
admin A think publicised in the Journal of the dweller Medical Association (JAMA) demonstrated that ingest of Abbott’s XIENCE™ V Everolimus Eluting Coronary Stent System in patients with thrombosis arteria disease resulted in a momentous 50 proportionality change in craft renarrowing (in-segment New los
Posted in Cardiology | 